Kwality Pharmaceuticals Limited (NSE:KPL)
India · Delayed Price · Currency is INR 2,697.50
+10.90 (0.41%)
At close: Jul 22, 2026
Kwality Pharmaceuticals Market Cap
Kwality Pharmaceuticals has a market cap or net worth of 27.99 billion as of July 22, 2026. Its market cap has increased by 135.59% in one year.
Market Cap
27.99B
Enterprise Value
29.24B
Revenue
5.03B
Ranking
n/a
PE Ratio
41.55
Stock Price
2,697.50
ChartMarket Cap Chart
Since July 18, 2016, Kwality Pharmaceuticals's market cap has increased from 230.87M to 27.99B, an increase of 12,021.80%. That is a compound annual growth rate of 61.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 27.99B | 143.34% |
| Dec 31, 2025 | 11.50B | 27.87% |
| Dec 31, 2024 | 8.99B | 116.81% |
| Dec 29, 2023 | 4.15B | 5.27% |
| Dec 30, 2022 | 3.94B | -58.55% |
| Dec 31, 2021 | 9.51B | 1,561.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bliss GVS Pharma | 51.90B |
| Unichem Laboratories | 41.89B |
| Novartis India | 41.30B |
| Gufic Biosciences | 39.47B |
| Morepen Laboratories | 31.91B |
| Kwality Pharmaceuticals | 28.68B |
| Hikal | 28.23B |
| Venus Remedies | 23.04B |